Anavex Life Sciences Corp (AVXL): NEW YORK — June 5, 2017

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	58
Posts	10055
Boards Moderated	1
Alias Born	09/21/2016

nidan7500

Re: blue finch post# 107721

Friday, 06/09/2017 9:31:28 AM

Friday, June 09, 2017 9:31:28 AM

NEW YORK — June 5, 2017 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain, and various types of cancer, today announced that Christopher U. Missling, PhD, President and Chief Executive Officer, is scheduled to present on Friday, June 9, 2017, at 10:00 a.m. Eastern Daylight Time, at the Jefferies 2017 Global Healthcare Conference in New York City.

A live webcast including audio and slides and subsequent archived replay presentation can be accessed at http://wsw.com/webcast/jeff105/avxl or via the investor material page of the Company’s website at http://www.anavex.com/investors/investor-material/.